SCHEMBL9895355

SCHEMBL9895355

CC(C)(C)[Si](C)(C)OCc1ccc2nc(N)oc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 1/20 0.45
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ USP2 O75604 1/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ LCK P06239 1/20 0.36
▸ MAPT P10636 4/20 0.36
▸ LMNA P02545 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ MTOR P42345 2/20 0.35
▸ RICTOR Q6R327 1/20 0.35
▸ RPTOR Q8N122 1/20 0.35
▸ MAPKAP1 Q9BPZ7 1/20 0.35
▸ MLST8 Q9BVC4 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.32
▸ MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14292518 0.78 PIK3CG (0.49) PIK3CGNPC1RAB9ASMN1; SMN2USP2
SCHEMBL253529 0.76 PIK3CG (0.56) PIK3CGNPC1RAB9ASMN1; SMN2USP2
SCHEMBL19405835 0.75 GPR119 (0.34) NPC1RAB9ALMNATHRBMEN1
SCHEMBL19406054 0.75 POLB (0.34) NPC1RAB9ASMN1; SMN2USP2MAPK10
SCHEMBL13699074 0.75 PIK3CG (0.45) PIK3CGNPC1RAB9ASMN1; SMN2USP2
SCHEMBL9380420 0.72 PIK3CG (0.56) PIK3CGNPC1RAB9ASMN1; SMN2USP2
SCHEMBL133816 0.72 MAOB (0.39) NPC1RAB9ASMN1; SMN2MAPTMAPK1
SCHEMBL13486442 0.72 PIK3CG (0.51) PIK3CGNPC1RAB9ASMN1; SMN2USP2
SCHEMBL5454226 0.72 SKP2 (0.44) NPC1RAB9ASMN1; SMN2MAPTTHRB
SCHEMBL2865322 0.72 ALDH1A1 (0.37) NPC1RAB9ASMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149718-A1 Amido Compounds P2RX7, P2RX3, P2RX2 PIK3CG 1781/4885NPC1 599/4885RAB9A 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback